The federal government and the private sector will have their work cut out for them encouraging people to get the vaccine, and telling them how to do so.
Regeneron’s experimental coronavirus treatment receives emergency use approval; Pfizer/BioNTech request emergency use approval for COVID-19 vaccine; Vaccine could be distributed as soon as 24-hours after receiving approval.
HHS pilot program brings rapid, POC coronavirus tests to five states; CDC: Americans should not travel for Thanksgiving; J&J makes a $100 million diversity pledge.
Plus people moves at EmpiRx Health, Open Health Group and CMI/Compas.
Pfizer/BioNTech vaccine proves safe and effective; COVID death and hospitalization numbers surge; Biden taps pharma lobbyist for administration.
Dr. Charlotte Jones-Burton, VP of Otsuka and president and co-founder of WOCIP, weighs in on recent statements concerning Vice-President-elect Kamala Harris’ Black heritage, and offers her take on other news.
This week’s Haymarket Media Coronavirus Briefing is 1,406 words and will take you seven minutes to read.
Americans can expect major changes to the nation’s approach toward healthcare following President-elect Joe Biden’s inauguration on January 20.
Amazon launches online pharmacy; J&J expect coronavirus vaccine trial data by Feb.; Sen. Rob Portman enrolls in J&J COVID-19 vaccine trial.
FDA to approve Moderna, Pfizer COVID-19 vaccines for emergency use as quickly as possible; Moderna’s coronavirus vaccine is 94.5% effective; 65 WHO employees have contracted the virus.